Deliverables approved
● AMBER5/12
Readiness score
● AMBER42%
across 4 workstreams
Critical risks open
● RED2
see Programme Overview
Recommendation
● GREENGO
with conditions on WS2 response plan
Deliverables checklist
| WS | Deliverable | Status |
|---|---|---|
| WS1 | European price map | Approved |
| WS1 | Leakage analysis | In review |
| WS1 | Affiliate data baseline | Draft |
| WS2 | Tender positioning report | In review |
| WS2 | Competitor evidence audit | Approved |
| WS2 | Live tender monitor | Draft |
| WS3 | Evidence inventory | Approved |
| WS3 | Gap analysis | Approved |
| WS3 | White space brief | In review |
| WS4 | Per-market route map | Approved |
| WS4 | Decision-maker register | In review |
| WS4 | Dossier requirements pack | Draft |
Phase 2 readiness scorecard
WS1 Pricing● AMBER
62% · 1/3 deliverables
WS2 Competitors● RED
48% · 1/3 deliverables
WS3 Evidence● GREEN
71% · 2/3 deliverables
WS4 Market Access● AMBER
55% · 1/3 deliverables
Recommendation
Proceed to Phase 2 - with conditions
The Intelligence Foundation has delivered a usable baseline across pricing, evidence and access. Recommend GO with two pre-conditions: (1) WS2 competitor response brief signed off by Med Affairs; (2) WS1 leakage analysis re-validated with IT & ES affiliates before pricing-framework work begins in Phase 2.
Phase 2 kickoff · 2026-10-14Sponsor sign-off · M. SandersonBudget envelope · approved